Trial Profile
Siponimod dose titrations in volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2011
Price :
$35
*
At a glance
- Drugs Siponimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Novartis
- 13 Apr 2011 New trial record